| Trial | Provider |
|---|---|
| Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Immunovant IMVT-1402-2401 | Gregory Sahagian MDPaul H. Janda DO |
| Early Cognitive Decline – Eli Lilly I5T-MC-AACV | Benjamin Frishberg MD |
| Generalized Myasthenia Gravis- Immunovant IMVT-1402-3102 | Tara Quesnell DO |
| Guillain Barre Syndrome – Annexon ANX005-GBS-05 | Gregory Sahagian MD |
| Multiple Sclerosis – Roche BP46016 | Benjamin Frishberg MD |
| Multiple Sclerosis – Roche CN46182 | Benjamin Frishberg MD |
| Myasthenia Gravis – Argenx ARGX-999-2-MG-2000 | Gregory Sahagian MDPaul H. Janda DO |
| Parkinson’s Disease – Appello Pharmaceuticals APLO-1201 | Irene Oh MD |
| Tremor – AbbVie M25-850 | Irene Oh MD |